Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ONCIMMUNE HOLDINGS PLC Director's Dealing 2021

Jan 14, 2021

7820_dirs_2021-01-14_7d10a64a-0737-4e7f-8d9e-1186f447639a.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 6923L

Oncimmune Holdings PLC

14 January 2021

Oncimmune Holdings plc

("Oncimmune" or the "Company")

PDMR Dealing

Oncimmune Holdings plc (AIM: ONC.L), the leading global immunodiagnostics group, has been notified on 13 January 2021 that Genostics Company Limited ("Genostics"), a Person Closely Associated ("PCA") (as that term is defined in the EU Market Abuse Regulation ("MAR")) with Dr Cheung To, a Non-Executive Director of the Company, has sold ordinary shares of £0.01 each in the Company ("Ordinary Shares") as follows:

Date No Ordinary Shares Price (£)
11 December 2020 10,000 1.65
14 December 2020 30,000 1.675
21 December 2020 5,000 1.70
5 January 2021 50,000 1.70
5 January 2021 50,000 1.75
8 January 2021 10,000 1.85
11 January 2021 40,000 1.85
Total 195,000

Following this transaction, Genostics has a total interest in the Company of 6,215,256 Ordinary Shares, representing approximately 9.8 per cent. of the Company's issued Ordinary Share capital.  

This announcement, including the notification below, is made in accordance with the requirements of Article 19 of MAR.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

Details of the person discharging managerial responsibilities / person closely associated
a) Name Genostics Company Limited
2 Reason for the notification
a) Position/status PCA of Dr Cheung To, Non-Executive Director of the Company
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Oncimmune Holdings plc
b) LEI 213800HCYIWT6YPI1I02
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code ISIN: GB00BYQ94H38
b) Nature of the transaction Disposal of shares
c) Price(s) and volume(s)
Price Volume
£1.65 10,000
d) Aggregated information
- Aggregated volume Same as above
- Price
e) Date of the transaction 11 December 2020
f) Place of the transaction London stock exchange, AIM
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code ISIN: GB00BYQ94H38
b) Nature of the transaction Disposal of shares
c) Price(s) and volume(s)
Price Volume
£1.675 30,000
d) Aggregated information
- Aggregated volume Same as above
- Price
e) Date of the transaction 14 December 2020
f) Place of the transaction London stock exchange, AIM
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code ISIN: GB00BYQ94H38
b) Nature of the transaction Disposal of shares
c) Price(s) and volume(s)
Price Volume
£1.70 5,000
d) Aggregated information
- Aggregated volume Same as above
- Price
e) Date of the transaction 21 December 2020
f) Place of the transaction London stock exchange, AIM
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code ISIN: GB00BYQ94H38
b) Nature of the transaction Disposal of shares
c) Price(s) and volume(s)
Price Volume
£1.70 50,000
d) Aggregated information
- Aggregated volume Same as above
- Price
e) Date of the transaction 5 January 2021
f) Place of the transaction London stock exchange, AIM
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code ISIN: GB00BYQ94H38
b) Nature of the transaction Disposal of shares
c) Price(s) and volume(s)
Price Volume
£1.75 50,000
d) Aggregated information
- Aggregated volume Same as above
- Price
e) Date of the transaction 5 January 2021
f) Place of the transaction London stock exchange, AIM
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code ISIN: GB00BYQ94H38
b) Nature of the transaction Disposal of shares
c) Price(s) and volume(s)
Price Volume
£1.85 10,000
d) Aggregated information
- Aggregated volume Same as above
- Price
e) Date of the transaction 8 January 2021
f) Place of the transaction London stock exchange, AIM
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code ISIN: GB00BYQ94H38
b) Nature of the transaction Disposal of shares
c) Price(s) and volume(s)
Price Volume
£1.85 40,000
d) Aggregated information
- Aggregated volume Same as above
- Price
e) Date of the transaction 11 January 2021
f) Place of the transaction London stock exchange, AIM

For further information:

Oncimmune Holdings plc

Ron Kirschner, General Counsel and Company Secretary

[email protected]  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHDKQBQCBKKFDD